Funding a better future for preterm babies
A collaborative project to improve breastfeeding and the use of human milk in premature babies has been awarded a $2.5 million grant from the National Health and Medical Research Council’s Centres of Research Excellence Scheme.
University of Birmingham to lead research on impact of denial of recourse to public...
University of Birmingham academics secure more than £700,000 to examine how the denial of recourse to public funds affects children living in the UK.
Asialink signals readiness for next phase of growth and impact with new CEO
Asialink has announced Rachel Thompson as its new Chief Executive Officer.
Hundreds of young people receive first Covid-19 jabs during two-day walk-in vaccination drive for...
A walk-in vaccination service at Kingston University saw hundreds of students, staff and young people aged 18 and over from across the borough visit campus to receive their first doses of the Pfizer vaccine.
Rice, Rutgers developing inhalable COVID-19 vaccine spray
Scientists at Rice University’s Center for Theoretical Biological Physics (CTBP) are part of a study to develop an inhalable COVID-19 vaccine.
First patient on trial in colorectal, gastric and ovarian cancer study
Newcastle biotechnology company ImmVirX Pty Limited has treated the first cancer patient in the clinical trial of its bio-selected oncolytic virus, IVX037.
AI and tech ideas take flight at NUS’ first Bay Area forum
Organised for the first time in San Francisco’s buzzing Bay Area, the two-day NUS Innovation Forum sparked a vibrant exchange of ideas between NUS alumni, students, thought leaders and industry experts.
Researchers uncover the hidden wonder of cells
Researchers from Telethon Kids Institute and The University of Western Australia have developed a new technique to see inside cells with unprecedented detail, revealing a complicated web of interactions that provides new insights into how cells stay healthy.
Ten University of Canterbury research projects gain MBIE funding
Ten University of Canterbury research projects tackling the big issues have been green-lit with funding worth $23 million.
University spinout company awarded £2.3 million to develop breakthrough therapies that address underlying causes...
Crucible Therapeutics and University of Sheffield secure a £2.3 million Innovate UK Biomedical Catalyst award to develop breakthrough siRNA therapies that address underlying causes of Motor Neuron Disease (MND).
